Disopyramide Phosphate

Disopyramide Phosphate Brand names, Disopyramide Phosphate Analogs

Disopyramide Phosphate Brand Names Mixture

No information avaliable

Disopyramide Phosphate Chemical_Formula

C₂₁H₂₉N₃O

Disopyramide Phosphate RX_link

http://www.rxlist.com/cgi/generic2/disopyr.htm

Disopyramide Phosphate fda sheet

Disopyramide Phosphate msds (material safety sheet)

Disopyramide Phosphate Synthesis Reference

No information avaliable

Disopyramide Phosphate Molecular Weight

339.475 g/mol

Disopyramide Phosphate Melting Point

94.5-95 ^oC

Disopyramide Phosphate H₂O Solubility

44.9 mg/L

Disopyramide Phosphate State

Solid

Disopyramide Phosphate LogP

3.972

Disopyramide Phosphate Dosage Forms

Capsule; Tablet (extended-release)

Disopyramide Phosphate Indication

For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, ventricular pre-excitation and cardiac dysrhythmias.

Disopyramide Phosphate Pharmacology

Disopyramide is an antiarrhythmic drug indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia that are life-threatening. In man, Disopyramide at therapeutic plasma levels shortens the sinus node recovery time, lengthens the effective refractory period of the atrium, and has a minimal effect on the effective refractory period of the AV node. Little effect has been shown on AV-nodal and His-Purkinje conduction times or QRS duration. However, prolongation of conduction in accessory pathways occurs.

Disopyramide Phosphate Absorption

Nearly complete

Disopyramide Phosphate side effects and Toxicity

LD₅₀=580 mg/kg in rats

Disopyramide Phosphate Patient Information